$MNKD
MANNKIND CORP Stock $mnkd

$mnkd Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000095017024021423 Filed on February 27, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$66.26M	$58.47M	$199.0M
YoY Change	63.1%	62.16%	99.42%
Cost Of Revenue	$3.819M	$18.07M	$20.86M
YoY Change	-30.94%	12.05%	30.37%
Gross Profit	$62.44M	$40.41M	$178.1M
YoY Change	77.92%	102.68%	112.61%
Gross Profit Margin	94.24%	69.1%	89.51%
Selling, General & Admin	$22.33M	$20.54M	$94.31M
YoY Change	-6.39%	-7.06%	3.11%
% of Gross Profit	35.76%	50.82%	52.96%
Research & Development	$10.01M	$9.236M	$31.28M
YoY Change	78.64%	29.07%	58.63%
% of Gross Profit	16.04%	22.86%	17.56%
Depreciation & Amortization	$1.341M	$1.225M	$4.500M
YoY Change	29.19%	-24.38%	36.36%
% of Gross Profit	2.15%	3.03%	2.53%
Operating Expenses	$18.60M	$29.77M	$62.77M
YoY Change	14.71%	1.78%	9.17%
Operating Profit	$16.72M	$10.63M	$8.678M
YoY Change	-378.79%	-214.15%	-113.54%
Interest Expense	$2.567M	-$7.508M	$15.15M
YoY Change	5.9%	-14.06%	58.62%
% of Operating Profit	15.35%	-70.6%	174.59%
Other Income/Expense, Net	-$5.828M	-$164.0K	-$19.06M
YoY Change	53.49%	-256.19%	-18.18%
Pretax Income	$10.89M	$2.962M	-$10.38M
YoY Change	-211.22%	-116.5%	-88.13%
Income Tax	$300.0K	$1.561M	$1.561M
% Of Pretax Income	2.75%	52.7%
Net Earnings	$10.63M	$1.401M	-$11.94M
YoY Change	-208.52%	-107.81%	-86.34%
Net Earnings / Revenue	16.04%	2.4%	-6.0%
Basic Earnings Per Share	$0.04		-$0.04
Diluted Earnings Per Share	$0.04	$0.01	-$0.04
COMMON SHARES
Basic Shares Outstanding	270.4M	269.6M	267.0M
Diluted Shares Outstanding	324.7M		267.0M

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$300.7M	$295.1M	$295.1M
YoY Change	81.01%	72.73%	72.73%
Cash & Equivalents	$193.3M	$238.5M	$238.5M
Short-Term Investments	$107.5M	$56.62M	$56.62M
Other Short-Term Assets	$36.02M	$34.85M	$34.85M
YoY Change	133.21%	36.78%	36.78%
Inventory	$26.44M	$28.55M	$28.55M
Prepaid Expenses
Receivables	$19.91M	$14.90M	$14.90M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$383.1M	$373.4M	$373.4M
YoY Change	71.56%	58.96%	58.96%
LONG-TERM ASSETS
Property, Plant & Equipment	$83.62M	$84.22M	$88.91M
YoY Change	52.49%	86.63%	97.02%
Goodwill	$1.900M	$1.900M
YoY Change	-5.0%	-20.83%
Intangibles	$1.053M	$1.073M
YoY Change	-7.06%	-6.94%
Long-Term Investments	$3.726M	$7.155M	$7.155M
YoY Change	657.32%	264.86%	264.86%
Other Assets	$7.447M	$7.426M	$2.741M
YoY Change	-54.53%	-23.59%	-71.79%
Total Long-Term Assets	$97.78M	$101.8M	$101.8M
YoY Change	30.65%	68.59%	68.59%
TOTAL ASSETS
Total Short-Term Assets	$383.1M	$373.4M	$373.4M
Total Long-Term Assets	$97.78M	$101.8M	$101.8M
Total Assets	$480.9M	$475.2M	$475.2M
YoY Change	61.29%	60.93%	60.93%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$7.149M	$9.580M	$9.580M
YoY Change	-48.53%	-13.32%	-13.32%
Accrued Expenses	$42.29M	$42.04M	$24.06M
YoY Change	28.17%	18.23%	31.89%
Deferred Revenue	$7.601M	$9.085M
YoY Change	228.2%	424.24%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$40.41M	$39.57M	$39.57M
YoY Change	89.78%	313.64%	313.64%
Total Short-Term Liabilities	$99.90M	$104.1M	$104.1M
YoY Change	22.04%	54.73%	54.73%
LONG-TERM LIABILITIES
Long-Term Debt	$475.8M	$479.1M	$479.1M
YoY Change	33.37%	30.18%	30.18%
Other Long-Term Liabilities	$135.2M	$138.2M	$138.2M
YoY Change	17.6%	25.01%	25.01%
Total Long-Term Liabilities	$611.0M	$617.2M	$617.2M
YoY Change	29.53%	28.99%	28.99%
TOTAL LIABILITIES
Total Short-Term Liabilities	$99.90M	$104.1M	$104.1M
Total Long-Term Liabilities	$611.0M	$617.2M	$617.2M
Total Liabilities	$710.8M	$721.4M	$721.4M
YoY Change	28.42%	32.16%	32.16%
SHAREHOLDERS EQUITY
Retained Earnings	-$3.219B	-$3.229B
YoY Change	-0.26%	0.37%
Common Stock	$2.989B	$2.983B
YoY Change	0.57%	0.55%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$230.0M	-$246.2M	-$246.2M
YoY Change
Total Liabilities & Shareholders Equity	$480.9M	$475.2M	$475.2M
YoY Change	61.29%	60.93%	60.93%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$10.63M	$1.401M	-$11.94M
YoY Change	-208.52%	-107.81%	-86.34%
Depreciation, Depletion And Amortization	$1.341M	$1.225M	$4.500M
YoY Change	29.19%	-24.38%	36.36%
Cash From Operating Activities	$6.703M	$21.68M	$34.09M
YoY Change	479.84%	-1012.37%	-142.26%
INVESTING ACTIVITIES
Capital Expenditures	$2.408M	$5.874M	$42.44M
YoY Change	-71.03%	15.27%	459.24%
Acquisitions
YoY Change
Other Investing Activities	-$46.03M	-$2.021M	$40.45M
YoY Change	-308.25%	-110.05%	224.58%
Cash From Investing Activities	-$48.44M	-$7.895M	-$1.988M
YoY Change	-451.2%	-152.6%	-140.79%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-3.474M	141.7M	136.6M
YoY Change	-401.04%	4915.26%	538.71%
NET CHANGE
Cash From Operating Activities	6.703M	21.68M	34.09M
Cash From Investing Activities	-48.44M	-7.895M	-1.988M
Cash From Financing Activities	-3.474M	141.7M	136.6M
Net Change In Cash	-45.21M	155.5M	168.7M
YoY Change	-380.76%	905.65%	-410.04%
FREE CASH FLOW
Cash From Operating Activities	$6.703M	$21.68M	$34.09M
Capital Expenditures	$2.408M	$5.874M	$42.44M
Free Cash Flow	$4.295M	$15.80M	-$8.347M
YoY Change	-160.03%	-311.51%	-90.54%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0000899460
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List OperatingLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAssetsNoncurrent
CY2023Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2022Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OperatingLeaseLiabilityNoncurrent
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OperatingLeaseLiabilityNoncurrent
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-50865
CY2023	dei	Entity Registrant Name EntityRegistrantName	MannKind Corporation
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	13-3607736
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	1 Casper Street
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Danbury
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	CT
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	06810
CY2023	dei	City Area Code CityAreaCode	818
CY2023	dei	Local Phone Number LocalPhoneNumber	661-5000
CY2023	dei	Security12b Title Security12bTitle	Common Stock, par value $0.01 per share
CY2023	dei	Trading Symbol TradingSymbol	MNKD
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	1084416366
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	270418215
CY2023	dei	Auditor Name AuditorName	Deloitte & Touche LLP
CY2023	dei	Auditor Location AuditorLocation	Los Angeles, California
CY2023	dei	Auditor Firm AuditorFirmId	34
CY2023	dei	Auditor Name AuditorName	Deloitte & Touche LLP
CY2023	dei	Auditor Location AuditorLocation	Los Angeles, California
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	198962000
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	267014000
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	267014000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	99770000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	75442000
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	20863000
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	16003000
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	16833000
CY2023	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	31283000
CY2022	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	19721000
CY2021	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	12312000
CY2023	us-gaap	Selling Expense SellingExpense	51776000
CY2022	us-gaap	Selling Expense SellingExpense	53753000
CY2021	us-gaap	Selling Expense SellingExpense	45528000
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	42538000
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	37720000
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	31889000
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	106000
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-1916000
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	4811000
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	6567000
CY2021	mnkd	Gain Loss On Purchase Commitments GainLossOnPurchaseCommitments	-339000
CY2023	us-gaap	Costs And Expenses CostsAndExpenses	190284000
CY2022	us-gaap	Costs And Expenses CostsAndExpenses	163880000
CY2021	us-gaap	Costs And Expenses CostsAndExpenses	122464000
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	8678000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-64110000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-47022000
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	6154000
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	2513000
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	112000
CY2023	mnkd	Interest Expense On Financing Liability InterestExpenseOnFinancingLiability	9825000
CY2022	mnkd	Interest Expense On Financing Liability InterestExpenseOnFinancingLiability	9758000
CY2021	mnkd	Interest Expense On Financing Liability InterestExpenseOnFinancingLiability	1373000
CY2023	us-gaap	Interest Expense InterestExpense	15151000
CY2022	us-gaap	Interest Expense InterestExpense	15011000
CY2021	us-gaap	Interest Expense InterestExpense	15204000
CY2023	us-gaap	Liability For Future Policy Benefit Interest Expense LiabilityForFuturePolicyBenefitInterestExpense	185000
CY2023	us-gaap	Debt Securities Available For Sale Gain Loss DebtSecuritiesAvailableForSaleGainLoss	-170000
CY2022	us-gaap	Debt Securities Available For Sale Gain Loss DebtSecuritiesAvailableForSaleGainLoss	-932000
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-17200000
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	122000
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-102000
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-239000
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-19055000
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-23290000
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-33904000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10377000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-87400000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-80926000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1561000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-11938000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-87400000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-80926000
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.34
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.34
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.32
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	257092000
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	257092000
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	249244000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	249244000
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	238480000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	69767000
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	56619000
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	101079000
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	14901000
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	16801000
CY2023Q4	us-gaap	Inventory Net InventoryNet	28545000
CY2022Q4	us-gaap	Inventory Net InventoryNet	21772000
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	34848000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	25477000
CY2023Q4	us-gaap	Assets Current AssetsCurrent	373393000
CY2022Q4	us-gaap	Assets Current AssetsCurrent	234896000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	84220000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	45126000
CY2023Q4	us-gaap	Goodwill Goodwill	1931000
CY2022Q4	us-gaap	Goodwill Goodwill	2428000
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1073000
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1153000
CY2023Q4	us-gaap	Long Term Investments LongTermInvestments	7155000
CY2022Q4	us-gaap	Long Term Investments LongTermInvestments	1961000
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	7426000
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	9718000
CY2023Q4	us-gaap	Assets Assets	475198000
CY2022Q4	us-gaap	Assets Assets	295282000
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	9580000
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	11052000
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	42036000
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	35553000
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	9809000
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	9565000
CY2023Q4	mnkd	Credit Facility Current CreditFacilityCurrent	20000000
CY2023Q4	mnkd	Liability Sale For Future Royalties Current LiabilitySaleForFutureRoyaltiesCurrent	9756000
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	9085000
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	1733000
CY2023Q4	mnkd	Purchase Obligation Current PurchaseObligationCurrent	3859000
CY2022Q4	mnkd	Purchase Obligation Current PurchaseObligationCurrent	9393000
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	104125000
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	67296000
CY2023Q4	mnkd	Convertible Notes Non Current ConvertibleNotesNonCurrent	8829000
CY2022Q4	mnkd	Convertible Notes Non Current ConvertibleNotesNonCurrent	8829000
CY2023Q4	mnkd	Accrued Interest Noncurrent AccruedInterestNoncurrent	56000
CY2022Q4	mnkd	Accrued Interest Noncurrent AccruedInterestNoncurrent	55000
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	94319000
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	94512000
CY2023Q4	mnkd	Credit Facility Noncurrent CreditFacilityNoncurrent	13019000
CY2022Q4	mnkd	Credit Facility Noncurrent CreditFacilityNoncurrent	39264000
CY2023Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	226851000
CY2022Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	225397000
CY2023Q4	mnkd	Liability Sale Of Future Royalties Non Current LiabilitySaleOfFutureRoyaltiesNonCurrent	136054000
CY2023Q4	mnkd	Purchase Obligation Noncurrent PurchaseObligationNoncurrent	60942000
CY2022Q4	mnkd	Purchase Obligation Noncurrent PurchaseObligationNoncurrent	62916000
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3925000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5343000
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	69794000
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	37684000
CY2023Q4	mnkd	Milestone Liabilities Noncurrent MilestoneLiabilitiesNoncurrent	3452000
CY2022Q4	mnkd	Milestone Liabilities Noncurrent MilestoneLiabilitiesNoncurrent	4524000
CY2023Q4	us-gaap	Liabilities Liabilities	721366000
CY2022Q4	us-gaap	Liabilities Liabilities	545820000
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	800000000
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	270034495
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	270034495
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	263793305
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	263793305
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	2700000
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	2638000
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2980539000
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2964293000
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3229407000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3217469000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-246168000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-250538000
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	475198000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	295282000
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-180419000
CY2021	mnkd	Stock Issued During Period Value Stock Options And Restricted Stock Units Net Of Forfeitures StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures	-498000
CY2021	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1090000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	12200000
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1886000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	38000
CY2021	mnkd	Adjustment To Additional Paid In Capital Premium On Convertible Note AdjustmentToAdditionalPaidInCapitalPremiumOnConvertibleNote	22107000
CY2021	mnkd	Stock Issued During Period Value Market Price Stock Purchase Plan StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan	106000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-80926000
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-209349000
CY2022	mnkd	Stock Issued During Period Value Stock Options And Restricted Stock Units Net Of Forfeitures StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures	319000
CY2022	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	2082000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	13447000
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	19790000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	381000
CY2022	mnkd	Stock Issued During Period Value Market Price Stock Purchase Plan StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan	684000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-87400000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-250538000
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	6887000
CY2023	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	108000
CY2023	mnkd	Stock Issued During Period Value Stock Options And Restricted Stock Units Net Of Forfeitures StockIssuedDuringPeriodValueStockOptionsAndRestrictedStockUnitsNetOfForfeitures	-10162000
CY2023	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1668000
CY2023	mnkd	Stock Issued During Period Value Market Price Stock Purchase Plan StockIssuedDuringPeriodValueMarketPriceStockPurchasePlan	152000
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	17649000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-11938000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-246168000
CY2023	us-gaap	Profit Loss ProfitLoss	-11938000
CY2022	us-gaap	Profit Loss ProfitLoss	-87400000
CY2021	us-gaap	Profit Loss ProfitLoss	-80926000
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	17649000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	13447000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	12200000
CY2023	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	4574000
CY2022	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	2202000
CY2021	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	1902000
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4535000
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	3325000
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1986000
CY2023	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2085000
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2092000
CY2021	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1709000
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	-1916000
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	4811000
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Realized ForeignCurrencyTransactionGainLossRealized	6567000
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1301000
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	2987000
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	1258000
CY2023	us-gaap	Debt Securities Available For Sale Gain Loss DebtSecuritiesAvailableForSaleGainLoss	-170000
CY2022	us-gaap	Debt Securities Available For Sale Gain Loss DebtSecuritiesAvailableForSaleGainLoss	-932000
CY2022	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	107340000
CY2021	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	59060000
CY2023	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	79095000
CY2022	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	74536000
CY2021	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	196131000
CY2023	mnkd	Interest On Liability For Sale Of Future Royalties InterestOnLiabilityForSaleOfFutureRoyalties	185000
CY2023	mnkd	Non Cash Interest On Financing Liability NonCashInterestOnFinancingLiability	31000
CY2022	mnkd	Non Cash Interest On Financing Liability NonCashInterestOnFinancingLiability	9552000
CY2021	mnkd	Non Cash Interest On Financing Liability NonCashInterestOnFinancingLiability	1372000
CY2023	mnkd	Net Accretion And Amortization Of Investments NetAccretionAndAmortizationOfInvestments	-925000
CY2022	mnkd	Net Accretion And Amortization Of Investments NetAccretionAndAmortizationOfInvestments	707000
CY2021	mnkd	Net Accretion And Amortization Of Investments NetAccretionAndAmortizationOfInvestments	520000
CY2023	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	339000
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-17000
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-17200000
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	106000
CY2021	mnkd	Interest On Milestone Payment InterestOnMilestonePayment	3663000
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2345000
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	11807000
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	776000
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	11347000
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5670000
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4081000
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	9421000
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	15552000
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	360000
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-263000
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-523000
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	138000
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-1473000
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4096000
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1374000
CY2023	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	6606000
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-723000
CY2021	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	8814000
CY2023	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	39462000
CY2022	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	19047000
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-14567000
CY2023	mnkd	Increase Decrease In Recognized Loss On Purchase Commitments IncreaseDecreaseInRecognizedLossOnPurchaseCommitments	-9424000
CY2022	mnkd	Increase Decrease In Recognized Loss On Purchase Commitments IncreaseDecreaseInRecognizedLossOnPurchaseCommitments	-5709000
CY2021	mnkd	Increase Decrease In Recognized Loss On Purchase Commitments IncreaseDecreaseInRecognizedLossOnPurchaseCommitments	-5892000
CY2023	mnkd	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-2385000
CY2022	mnkd	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-3309000
CY2021	mnkd	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	-2135000
CY2021	mnkd	Increase Decrease In Accrued Interest On Convertible Notes IncreaseDecreaseInAccruedInterestOnConvertibleNotes	4919000
CY2022	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	-4950000
CY2021	us-gaap	Increase Decrease In Other Noncurrent Liabilities IncreaseDecreaseInOtherNoncurrentLiabilities	4950000
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	34094000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-80679000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-61709000
CY2023	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	119166000
CY2021	us-gaap	Interest Paid Net InterestPaidNet	11268000
CY2023	mnkd	Reclassification Of Credit Facility From Long Term To Current ReclassificationOfCreditFacilityFromLongTermToCurrent	26667000
CY2023	mnkd	Reclassification Of Investments From Long Term To Current ReclassificationOfInvestmentsFromLongTermToCurrent	6404000
CY2022	mnkd	Reclassification Of Investments From Long Term To Current ReclassificationOfInvestmentsFromLongTermToCurrent	82850000
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	42441000
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7589000
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	11466000
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	15341000
CY2023	us-gaap	Proceeds From Insurance Settlement Investing Activities ProceedsFromInsuranceSettlementInvestingActivities	382000
CY2022	mnkd	Purchase Of Available For Sale Securities PurchaseOfAvailableForSaleSecurities	5000000
CY2021	mnkd	Purchase Of Available For Sale Securities PurchaseOfAvailableForSaleSecurities	3000000
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1988000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	4874000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-151537000
CY2023	mnkd	Proceeds From Sale Of Future Royalties ProceedsFromSaleOfFutureRoyalties	150000000
CY2023	mnkd	Issuance Costs Associated With Sale Of Future Royalties IssuanceCostsAssociatedWithSaleOfFutureRoyalties	4050000
CY2023	mnkd	Proceeds From Market Price Stock Purchase Plan And From Employee Stock Purchase Plan ProceedsFromMarketPriceStockPurchasePlanAndFromEmployeeStockPurchasePlan	1820000
CY2022	mnkd	Proceeds From Market Price Stock Purchase Plan And From Employee Stock Purchase Plan ProceedsFromMarketPriceStockPurchasePlanAndFromEmployeeStockPurchasePlan	2766000
CY2021	mnkd	Proceeds From Market Price Stock Purchase Plan And From Employee Stock Purchase Plan ProceedsFromMarketPriceStockPurchasePlanAndFromEmployeeStockPurchasePlan	106000
CY2023	mnkd	Payments For Taxes Related To Net Issuance Of Common Stock Associated With Restricted Stock Units And Stock Options PaymentsForTaxesRelatedToNetIssuanceOfCommonStockAssociatedWithRestrictedStockUnitsAndStockOptions	10162000
CY2022	mnkd	Payments For Taxes Related To Net Issuance Of Common Stock Associated With Restricted Stock Units And Stock Options PaymentsForTaxesRelatedToNetIssuanceOfCommonStockAssociatedWithRestrictedStockUnitsAndStockOptions	-319000
CY2021	mnkd	Payments For Taxes Related To Net Issuance Of Common Stock Associated With Restricted Stock Units And Stock Options PaymentsForTaxesRelatedToNetIssuanceOfCommonStockAssociatedWithRestrictedStockUnitsAndStockOptions	498000
CY2023	mnkd	Principal Payment On Financing Liability PrincipalPaymentOnFinancingLiability	189000
CY2022	mnkd	Principal Payment On Financing Liability PrincipalPaymentOnFinancingLiability	18000
CY2023	mnkd	Milestone Payments MilestonePayments	924000
CY2022	mnkd	Milestone Payments MilestonePayments	1088000
CY2021	mnkd	Milestone Payments MilestonePayments	5000000
CY2021	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	230000000
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	7268000
CY2021	mnkd	Proceeds From Sale Leaseback Transaction ProceedsFromSaleLeasebackTransaction	102250000
CY2021	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	3120000
CY2021	mnkd	Deposit For Sale Leaseback Transaction DepositForSaleLeasebackTransaction	2000000
CY2021	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	35051000
CY2023	mnkd	Payment On Mid Cap Credit Facility PaymentOnMidCapCreditFacility	6667000
CY2021	mnkd	Payment On Mid Cap Credit Facility PaymentOnMidCapCreditFacility	10000000
CY2021	mnkd	Payment Of Credit Facility Prepayment Penalty PaymentOfCreditFacilityPrepaymentPenalty	1000000
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	136607000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	21388000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	270267000
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	168713000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-54417000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	57021000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	69767000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	124184000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	67163000
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	238480000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	69767000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	124184000
CY2023	us-gaap	Interest Paid Net InterestPaidNet	18279000
CY2022	us-gaap	Interest Paid Net InterestPaidNet	8852000
CY2021	mnkd	Reclassification Of Investments From Long Term To Current ReclassificationOfInvestmentsFromLongTermToCurrent	32654000
CY2023	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1691000
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1298000
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1264000
CY2023	mnkd	Right Of Use Assets Modification RightOfUseAssetsModification	728000
CY2022	mnkd	Right Of Use Assets Modification RightOfUseAssetsModification	3793000
CY2021	mnkd	Right Of Use Assets Modification RightOfUseAssetsModification	278000
CY2023	mnkd	Goodwill Adjustment For A Net Reduction In Liabilities GoodwillAdjustmentForANetReductionInLiabilities	497000
CY2023	mnkd	Receivable For Insurance Claim On Damaged Equipment ReceivableForInsuranceClaimOnDamagedEquipment	445000
CY2023	mnkd	Accrued Issuance Costs Associated With Liability For Sale Of Future Royalties AccruedIssuanceCostsAssociatedWithLiabilityForSaleOfFutureRoyalties	325000
CY2023	mnkd	Payments On Debt And Interest Through Common Stock Issuance PaymentsOnDebtAndInterestThroughCommonStockIssuance	222000
CY2022	mnkd	Payments On Debt And Interest Through Common Stock Issuance PaymentsOnDebtAndInterestThroughCommonStockIssuance	10270000
CY2021	mnkd	Payments On Debt And Interest Through Common Stock Issuance PaymentsOnDebtAndInterestThroughCommonStockIssuance	15143000
CY2022	mnkd	Reclassification Of Convertible Notes And Interest Receivable ReclassificationOfConvertibleNotesAndInterestReceivable	7375000
CY2021	mnkd	Common Stock Issuance To Settle Employee Stock Purchase Plan Liability CommonStockIssuanceToSettleEmployeeStockPurchasePlanLiability	1090000
CY2022	mnkd	Addition Of Right Of Use Assets AdditionOfRightOfUseAssets	1812000
CY2021	mnkd	Addition Of Right Of Use Assets AdditionOfRightOfUseAssets	1425000
CY2022	mnkd	Contingent Milestone Liability ContingentMilestoneLiability	610000
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Reclassifications</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> — Certain amounts reported in prior years have been reclassified to conform with the current year presentation. Changes were made to the consolidated statements of cash flows to present the amortization of debt discount and issuance costs and net investment (accretion) amortization separately from amortization and depreciation expense. Additionally, changes were made to our effective income tax rate reconciliation table in Note 18</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;"> – Income Taxes</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> to separate officers compensation from permanent items</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">.</span></p>
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Financial Statement Estimates</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> — The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and notes. Actual results could differ from those estimates or assumptions. Management considers many factors in selecting appropriate financial accounting policies, and in developing the estimates and assumptions that are used in the preparation of the financial statements. Management must apply significant judgment in this process. These effects could have a material impact on the estimates and assumptions used in the preparation of the consolidated financial statements. The more significant estimates include revenue recognition, including gross-to-net adjustments, stand-alone selling price considerations for recognition of collaboration revenue, assessing long-lived assets for impairment, clinical trial expenses, inventory costing and recoverability, recognized loss on purchase commitment, stock-based compensation, the determination of the provision for income taxes and corresponding deferred tax assets and liabilities, the valuation allowance recorded against net deferred tax assets, and expected cash flows from royalties received in connection with UT's net revenue for the sale of Tyvaso DPI.</span></p>
CY2023	mnkd	Percentage Of Future Royalties PercentageOfFutureRoyalties	0.01
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	198962000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	99770000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	75442000
CY2023	us-gaap	Operating Expenses OperatingExpenses	62771000
CY2022	us-gaap	Operating Expenses OperatingExpenses	57497000
CY2021	us-gaap	Operating Expenses OperatingExpenses	38857000
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Concentration of Credit Risk</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> — Financial instruments that potentially subject the Company to concentration of credit risk consisted of cash and cash equivalents and investments. Cash and cash equivalents are held in high credit quality institutions. Cash equivalents consisted of interest-bearing money market funds and U.S. Treasury securities with original or remaining maturities of 90 days or less at the time of purchase. Investments generally consisted of commercial paper, corporate notes or bonds and U.S. Treasury securities. The cash equivalents and investments are regularly monitored by management.</span>
CY2022Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0725
CY2023	mnkd	Interest And Dividend Income Debt Securities Available For Sale InterestAndDividendIncomeDebtSecuritiesAvailableForSale	500000
CY2022	mnkd	Interest And Dividend Income Debt Securities Available For Sale InterestAndDividendIncomeDebtSecuritiesAvailableForSale	500000
CY2023	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	1600000
CY2022	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	700000
CY2022Q4	us-gaap	Debt Securities Held To Maturity Allowance For Credit Loss DebtSecuritiesHeldToMaturityAllowanceForCreditLoss	0
CY2023Q4	us-gaap	Debt Securities Held To Maturity Allowance For Credit Loss DebtSecuritiesHeldToMaturityAllowanceForCreditLoss	0
CY2023Q4	us-gaap	Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount	115263000
CY2023Q4	us-gaap	Held To Maturity Securities Debt Maturities Within One Year Fair Value HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue	115374000
CY2022Q4	us-gaap	Held To Maturity Securities Debt Maturities Within One Year Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearNetCarryingAmount	152862000
CY2022Q4	us-gaap	Held To Maturity Securities Debt Maturities Within One Year Fair Value HeldToMaturitySecuritiesDebtMaturitiesWithinOneYearFairValue	156976000
CY2023Q4	us-gaap	Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount	7155000
CY2023Q4	us-gaap	Held To Maturity Securities Debt Maturities After One Through Five Years Fair Value HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	7197000
CY2022Q4	us-gaap	Held To Maturity Securities Debt Maturities After One Through Five Years Net Carrying Amount HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsNetCarryingAmount	1961000
CY2022Q4	us-gaap	Held To Maturity Securities Debt Maturities After One Through Five Years Fair Value HeldToMaturitySecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	1948000
CY2023Q4	us-gaap	Held To Maturity Securities Debt Maturities Single Maturity Date Amortized Cost Basis HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis	122418000
CY2023Q4	us-gaap	Held To Maturity Securities Debt Maturities Single Maturity Date Fair Value HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValue	122571000
CY2022Q4	us-gaap	Held To Maturity Securities Debt Maturities Single Maturity Date Amortized Cost Basis HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis	154823000
CY2022Q4	us-gaap	Held To Maturity Securities Debt Maturities Single Maturity Date Fair Value HeldToMaturitySecuritiesDebtMaturitiesSingleMaturityDateFairValue	158924000
CY2022Q4	mnkd	Accrued Interest Receivable AccruedInterestReceivable	600000
CY2022Q4	mnkd	Amount Receivable On Matured Investment AmountReceivableOnMaturedInvestment	5100000
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	14901000
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	16801000
CY2022	mnkd	Number Of Wholesale Distributors NumberOfWholesaleDistributors	3
CY2023	mnkd	Number Of Wholesale Distributors NumberOfWholesaleDistributors	3
CY2023	mnkd	Percentage Of Sales From Major Customers PercentageOfSalesFromMajorCustomers	0.85
CY2022	mnkd	Percentage Of Sales From Major Customers PercentageOfSalesFromMajorCustomers	0.74
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0
CY2023	mnkd	Percentage Of Revenue From Major Customers Collaborations And Services PercentageOfRevenueFromMajorCustomersCollaborationsAndServices	1
CY2022	mnkd	Percentage Of Revenue From Major Customers Collaborations And Services PercentageOfRevenueFromMajorCustomersCollaborationsAndServices	0.98
CY2022Q4	mnkd	Prompt Pay Discount Reserve Allowance For Wholesale Distribution Fees And Accounts Receivables Return Reserve PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserve	6644000
CY2021Q4	mnkd	Prompt Pay Discount Reserve Allowance For Wholesale Distribution Fees And Accounts Receivables Return Reserve PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserve	4493000
CY2023	mnkd	Prompt Pay Discount Reserve Allowance For Wholesale Distribution Fees And Accounts Receivables Return Reserve Provisions PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveProvisions	18977000
CY2022	mnkd	Prompt Pay Discount Reserve Allowance For Wholesale Distribution Fees And Accounts Receivables Return Reserve Provisions PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveProvisions	17471000
CY2023	mnkd	Prompt Pay Discount Reserve Allowance For Wholesale Distribution Fees And Accounts Receivables Return Reserve Deductions PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveDeductions	-16780000
CY2022	mnkd	Prompt Pay Discount Reserve Allowance For Wholesale Distribution Fees And Accounts Receivables Return Reserve Deductions PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserveDeductions	-15320000
CY2023Q4	mnkd	Prompt Pay Discount Reserve Allowance For Wholesale Distribution Fees And Accounts Receivables Return Reserve PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserve	8841000
CY2022Q4	mnkd	Prompt Pay Discount Reserve Allowance For Wholesale Distribution Fees And Accounts Receivables Return Reserve PromptPayDiscountReserveAllowanceForWholesaleDistributionFeesAndAccountsReceivablesReturnReserve	6644000
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	6262000
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	5739000
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	13646000
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	13815000
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	8637000
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	2218000
CY2023Q4	us-gaap	Inventory Net InventoryNet	28545000
CY2022Q4	us-gaap	Inventory Net InventoryNet	21772000
CY2023	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	4600000
CY2022	us-gaap	Production Related Impairments Or Charges ProductionRelatedImpairmentsOrCharges	2200000
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	185756000
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	143686000
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	101536000
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	98560000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	84220000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	45126000
CY2023	us-gaap	Depreciation Depreciation	4500000
CY2022	us-gaap	Depreciation Depreciation	3300000
CY2021	us-gaap	Depreciation Depreciation	2000000
CY2023Q4	mnkd	Net Book Value Of Disposed Assets NetBookValueOfDisposedAssets	600000
CY2023Q4	us-gaap	Goodwill Goodwill	1900000
CY2022Q4	us-gaap	Goodwill Goodwill	2400000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	100000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	100000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	100000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	100000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	100000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	700000
CY2022	mnkd	Discounts And Allowances For Commercial Product Sales Deductions DiscountsAndAllowancesForCommercialProductSalesDeductions	20603000
CY2022	mnkd	Discounts And Allowances For Commercial Product Sales Balances From Acquisition DiscountsAndAllowancesForCommercialProductSalesBalancesFromAcquisition	1511000
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	19506000
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	14906000
CY2023Q4	mnkd	Customer Discounts And Allowances CustomerDiscountsAndAllowances	9541000
CY2022Q4	mnkd	Customer Discounts And Allowances CustomerDiscountsAndAllowances	8504000
CY2023Q4	us-gaap	Interest Payable Current InterestPayableCurrent	2153000
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	2201000
CY2023Q4	mnkd	Deferred State And Local Income Tax Expense DeferredStateAndLocalIncomeTaxExpense	1561000
CY2023Q4	us-gaap	Direct Financing Lease Deferred Selling Profit DirectFinancingLeaseDeferredSellingProfit	1423000
CY2022Q4	us-gaap	Direct Financing Lease Deferred Selling Profit DirectFinancingLeaseDeferredSellingProfit	1304000
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	979000
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	1136000
CY2023Q4	mnkd	Current Portion Of Milestone Right Liability CurrentPortionOfMilestoneRightLiability	752000
CY2022Q4	mnkd	Current Portion Of Milestone Right Liability CurrentPortionOfMilestoneRightLiability	924000
CY2023Q4	mnkd	Returns Reserve For Acquired Product ReturnsReserveForAcquiredProduct	601000
CY2022Q4	mnkd	Returns Reserve For Acquired Product ReturnsReserveForAcquiredProduct	1013000
CY2023Q4	us-gaap	Construction Payable Current ConstructionPayableCurrent	316000
CY2022Q4	us-gaap	Construction Payable Current ConstructionPayableCurrent	846000
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	5204000
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	4719000
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	42036000
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	35553000
CY2022Q4	mnkd	Discounts And Allowances For Commercial Product Sales DiscountsAndAllowancesForCommercialProductSales	8504000
CY2021Q4	mnkd	Discounts And Allowances For Commercial Product Sales DiscountsAndAllowancesForCommercialProductSales	4227000
CY2023	mnkd	Discounts And Allowances For Commercial Product Sales Provisions DiscountsAndAllowancesForCommercialProductSalesProvisions	34980000
CY2022	mnkd	Discounts And Allowances For Commercial Product Sales Provisions DiscountsAndAllowancesForCommercialProductSalesProvisions	23369000
CY2023	mnkd	Discounts And Allowances For Commercial Product Sales Deductions DiscountsAndAllowancesForCommercialProductSalesDeductions	33943000
CY2023Q4	mnkd	Discounts And Allowances For Commercial Product Sales DiscountsAndAllowancesForCommercialProductSales	9541000
CY2022Q4	mnkd	Discounts And Allowances For Commercial Product Sales DiscountsAndAllowancesForCommercialProductSales	8504000
CY2023Q4	us-gaap	Senior Notes SeniorNotes	226851000
CY2022Q4	us-gaap	Senior Notes SeniorNotes	225397000
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	268699000
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	273490000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	20000000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	22163000
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	230000000
CY2023Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	272163000
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	313000
CY2023Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	3151000
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	268699000
CY2023	us-gaap	Debt Instrument Frequency Of Periodic Payment DebtInstrumentFrequencyOfPeriodicPayment	Principal on each term loan advance under Tranche 1 and Tranche 2 are payable in 24 equal monthly installments that began September 1, 2023, until paid in full on August 1, 2025.
CY2019Q3	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2024-11-03
CY2021Q2	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2025-12-31
CY2023	mnkd	Amortization Of Debt Discount And Prepayment Fee AmortizationOfDebtDiscountAndPrepaymentFee	423000
CY2022	mnkd	Amortization Of Debt Discount And Prepayment Fee AmortizationOfDebtDiscountAndPrepaymentFee	431000
CY2021	mnkd	Amortization Of Debt Discount And Prepayment Fee AmortizationOfDebtDiscountAndPrepaymentFee	377000
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1454000
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1453000
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1215000
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	39417000
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	20370000
CY2023	mnkd	Contract With Customer Liability Additions ContractWithCustomerLiabilityAdditions	92416000
CY2022	mnkd	Contract With Customer Liability Additions ContractWithCustomerLiabilityAdditions	46971000
CY2023	mnkd	Contract With Customer Liability Collaborations And Services Revenue ContractWithCustomerLiabilityCollaborationsAndServicesRevenue	-52954000
CY2022	mnkd	Contract With Customer Liability Collaborations And Services Revenue ContractWithCustomerLiabilityCollaborationsAndServicesRevenue	-27924000
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	78879000
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	39417000
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	800000000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	800000000
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	270034495
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	270034495
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	263793305
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	263793305
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2021	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	100000
CY2021	mnkd	Market Price Stock Purchase Plan MarketPriceStockPurchasePlan	25000
CY2022	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	700000
CY2022	mnkd	Market Price Stock Purchase Plan MarketPriceStockPurchasePlan	252176
CY2023	us-gaap	Proceeds From Stock Plans ProceedsFromStockPlans	200000
CY2023	mnkd	Market Price Stock Purchase Plan MarketPriceStockPurchasePlan	36004
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-11938000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-87400000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-80926000
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	267014000
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	257092000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	249244000
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.04
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.04
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.34
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.34
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.32
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	63746218
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	75451760
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	69998009
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8400611
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	12363934
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	26374063
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	17649000
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	13447000
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	12200000
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	9074587
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.06
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y1M6D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	29512000
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	445376
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.57
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	3420
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.53
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	225180
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	30.97
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	8400611
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.39
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y25D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	15153000
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	7938892
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.40
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1	P4Y1M13D
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	14450000
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	0
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	0
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	2800000
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	3200000
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	2300000
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1300000
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	2400000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1700000
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1200000
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3000000.0
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	1000000.0
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	11838329
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	3.65
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	7531650
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	5.17
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	6053264
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	3.41
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	952781
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	4.80
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	12363934
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	4.61
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	20600000
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	4400000
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Total Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue	6700000
CY2023Q4	mnkd	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options In Period Grant Date Fair Value Outstanding ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsInPeriodGrantDateFairValueOutstanding	57000000
CY2022Q4	mnkd	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options In Period Grant Date Fair Value Outstanding ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsInPeriodGrantDateFairValueOutstanding	43200000
CY2021Q4	mnkd	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options In Period Grant Date Fair Value Outstanding ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsInPeriodGrantDateFairValueOutstanding	19300000
CY2023Q2	mnkd	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant Increased By Shares ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrantIncreasedByShares	3000000
CY2023	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	200000
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	104100000
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	94300000
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	9800000
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	104100000
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	94500000
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	9600000
CY2023	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	9600000
CY2022	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	9600000
CY2023Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P17Y9M18D
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P18Y9M18D
CY2023Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.09
CY2022Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.09
CY2023	mnkd	Interest Expense On Financing Liability InterestExpenseOnFinancingLiability	9825000
CY2022	mnkd	Interest Expense On Financing Liability InterestExpenseOnFinancingLiability	9758000
CY2021	mnkd	Interest Expense On Financing Liability InterestExpenseOnFinancingLiability	1373000
CY2023Q4	mnkd	Finance Lease Liability Discounted Payments Due Next Twelve Months FinanceLeaseLiabilityDiscountedPaymentsDueNextTwelveMonths	10018000
CY2023Q4	mnkd	Finance Lease Liability Discounted Payments Due Year Two FinanceLeaseLiabilityDiscountedPaymentsDueYearTwo	10269000
CY2023Q4	mnkd	Finance Lease Liability Discounted Payments Due Year Three FinanceLeaseLiabilityDiscountedPaymentsDueYearThree	10533000
CY2023Q4	mnkd	Finance Lease Liability Discounted Payments Due Year Four FinanceLeaseLiabilityDiscountedPaymentsDueYearFour	10849000
CY2023Q4	mnkd	Finance Lease Liability Discounted Payments Due Year Five FinanceLeaseLiabilityDiscountedPaymentsDueYearFive	11174000
CY2023Q4	mnkd	Finance Lease Liability Discounted Payments Due After Year Five FinanceLeaseLiabilityDiscountedPaymentsDueAfterYearFive	177278000
CY2023Q4	mnkd	Finance Lease Liability Discounted Payments Due FinanceLeaseLiabilityDiscountedPaymentsDue	230121000
CY2023Q4	mnkd	Finance Lease Liability Discounted Excess Amount FinanceLeaseLiabilityDiscountedExcessAmount	123318000
CY2023Q4	mnkd	Finance Lease Liability Discounted Debt Issuance Costs FinanceLeaseLiabilityDiscountedDebtIssuanceCosts	2675000
CY2023Q4	mnkd	Finance Lease Liability Discounted FinanceLeaseLiabilityDiscounted	104128000
CY2023Q3	us-gaap	Purchase Obligation Future Minimum Payments Remainder Of Fiscal Year PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear	2400000
CY2023Q4	us-gaap	Purchase Obligation Due In Next Twelve Months PurchaseObligationDueInNextTwelveMonths	2900000
CY2023Q3	us-gaap	Purchase Obligation Due In Next Twelve Months PurchaseObligationDueInNextTwelveMonths	14600000
CY2023Q4	mnkd	Estimated Capacity Fees Due In Second Year EstimatedCapacityFeesDueInSecondYear	1500000
CY2023Q3	us-gaap	Purchase Obligation Due In Second Year PurchaseObligationDueInSecondYear	15500000
CY2023Q4	us-gaap	Purchase Obligation Due In Third Year PurchaseObligationDueInThirdYear	4200000
CY2023Q4	mnkd	Estimated Capacity Fees Due In Third Year EstimatedCapacityFeesDueInThirdYear	2000000
CY2023Q3	us-gaap	Purchase Obligation Due In Third Year PurchaseObligationDueInThirdYear	19400000
CY2023Q4	us-gaap	Purchase Obligation Due In Fourth Year PurchaseObligationDueInFourthYear	6000000
CY2023Q4	mnkd	Estimated Capacity Fees Due In Fourth Year EstimatedCapacityFeesDueInFourthYear	1000000
CY2023Q3	us-gaap	Purchase Obligation Due In Fourth Year PurchaseObligationDueInFourthYear	9200000
CY2023Q4	us-gaap	Purchase Obligation Due In Fifth Year PurchaseObligationDueInFifthYear	6000000
CY2023Q4	mnkd	Estimated Capacity Fees Due In Fifth Year EstimatedCapacityFeesDueInFifthYear	1000000
CY2023Q4	mnkd	Purchase Obligation Due In Sixth Year PurchaseObligationDueInSixthYear	6000000
CY2023Q4	mnkd	Estimated Capacity Fees Due In Sixth Year EstimatedCapacityFeesDueInSixthYear	1000000
CY2023Q4	mnkd	Purchase Obligation Due In Seventh Year PurchaseObligationDueInSeventhYear	6000000
CY2023Q4	mnkd	Estimated Capacity Fees Due In Seventh Year EstimatedCapacityFeesDueInSeventhYear	1000000
CY2023Q4	mnkd	Purchase Obligation Due In Eighth Year PurchaseObligationDueInEighthYear	8000000
CY2023Q4	mnkd	Estimated Capacity Fees Due In Eighth Year EstimatedCapacityFeesDueInEighthYear	500000
CY2023Q4	mnkd	Purchase Obligation Due In Nineth Year PurchaseObligationDueInNinethYear	8000000
CY2023Q4	mnkd	Estimated Capacity Fees Due In Ninth Year EstimatedCapacityFeesDueInNinthYear	500000
CY2023Q4	mnkd	Purchase Obligation Due In Tenth Year PurchaseObligationDueInTenthYear	8000000
CY2023Q4	mnkd	Estimated Capacity Fees Due In Tenth Year EstimatedCapacityFeesDueInTenthYear	500000
CY2023Q4	mnkd	Purchase Obligation Due In Eleventh Year PurchaseObligationDueInEleventhYear	4400000
CY2023Q4	mnkd	Estimated Capacity Fees Due In Eleventh Year EstimatedCapacityFeesDueInEleventhYear	500000
CY2023Q4	us-gaap	Purchase Obligation PurchaseObligation	59500000
CY2023Q4	mnkd	Estimated Capacity Fees EstimatedCapacityFees	9500000
CY2023Q4	mnkd	Deferred Tax Assets Capitalized Costs DeferredTaxAssetsCapitalizedCosts	6720000
CY2022Q4	mnkd	Deferred Tax Assets Capitalized Costs DeferredTaxAssetsCapitalizedCosts	8058000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	3405000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	3204000
CY2023Q4	mnkd	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	1280000
CY2022Q4	mnkd	Deferred Tax Assets Lease Liabilities DeferredTaxAssetsLeaseLiabilities	1624000
CY2023Q4	mnkd	Deferred Tax Assets Interest Expense Limitation DeferredTaxAssetsInterestExpenseLimitation	2782000
CY2023Q3	us-gaap	Purchase Obligation PurchaseObligation	61100000
CY2023Q4	mnkd	Capacity Fee CapacityFee	750000
CY2023	mnkd	Long Term Purchase Commitment Expiration Date LongTermPurchaseCommitmentExpirationDate	2034-12-31
CY2023	mnkd	Longterm Purchase Commitment Renewal Time Period LongtermPurchaseCommitmentRenewalTimePeriod	P2Y
CY2023	us-gaap	Lessee Operating Lease Option To Extend LesseeOperatingLeaseOptionToExtend	The Company has no further right to extend the lease term beyond July 31, 2028.
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	4685000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	6714000
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1423000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1304000
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3925000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5343000
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	5348000
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	6647000
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y8M12D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y7M6D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.073
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.073
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	1675000
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	1525000
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	863000
CY2023	us-gaap	Variable Lease Cost VariableLeaseCost	104000
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	274000
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	515000
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	1068000
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	1823000
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	1867000
CY2023	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	0.50
CY2022	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	0.50
CY2021	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent Of Match DefinedContributionPlanEmployerMatchingContributionPercentOfMatch	0.50
CY2023	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	2900000
CY2022	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	1800000
CY2021	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	1500000
CY2022Q4	mnkd	Deferred Tax Assets Interest Expense Limitation DeferredTaxAssetsInterestExpenseLimitation	10991000
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	21134000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-10377000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-87400000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-80926000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10377000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-87400000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-80926000
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	1555000
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1555000
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	190000
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-5606000
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-5170000
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	7002000
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-4334000
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-14461000
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	6812000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-9940000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-19631000
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-9940000
CY2021	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-19631000
CY2023	mnkd	Net Deferred Income Tax Expense Benefit NetDeferredIncomeTaxExpenseBenefit	6
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1561000
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	506641000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	542537000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	77007000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	78804000
CY2023Q4	mnkd	Deferred Tax Assets Capitalized Research Expenses DeferredTaxAssetsCapitalizedResearchExpenses	14225000
CY2022Q4	mnkd	Deferred Tax Assets Capitalized Research Expenses DeferredTaxAssetsCapitalizedResearchExpenses	4369000
CY2023Q4	mnkd	Deferred Tax Assets Milestone Rights DeferredTaxAssetsMilestoneRights	1006000
CY2022Q4	mnkd	Deferred Tax Assets Milestone Rights DeferredTaxAssetsMilestoneRights	1331000
CY2023Q4	mnkd	Deferred Tax Assets Tax Deferred Expense Accrual Adjustment DeferredTaxAssetsTaxDeferredExpenseAccrualAdjustment	3760000
CY2022Q4	mnkd	Deferred Tax Assets Tax Deferred Expense Accrual Adjustment DeferredTaxAssetsTaxDeferredExpenseAccrualAdjustment	2675000
CY2023Q4	mnkd	Deferred Tax Assets Loss On Purchase Commitment DeferredTaxAssetsLossOnPurchaseCommitment	22806000
CY2022Q4	mnkd	Deferred Tax Assets Loss On Purchase Commitment DeferredTaxAssetsLossOnPurchaseCommitment	23117000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3559000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	7686000
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	22157000
CY2023Q4	mnkd	Deferred Tax Assets Product Revenue And Costs DeferredTaxAssetsProductRevenueAndCosts	346000
CY2022Q4	mnkd	Deferred Tax Assets Product Revenue And Costs DeferredTaxAssetsProductRevenueAndCosts	370000
CY2023Q4	mnkd	Deferred Tax Assets Sale Of Future Royalties DeferredTaxAssetsSaleOfFutureRoyalties	34848000
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	699519000
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	706923000
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	698228000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	705034000
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1291000
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	1889000
CY2023Q4	mnkd	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	1121000
CY2022Q4	mnkd	Deferred Tax Liabilities Right Of Use Asset DeferredTaxLiabilitiesRightOfUseAsset	1640000
CY2023Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	176000
CY2022Q4	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	249000
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1297000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	1889000
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	6000
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.118
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0
CY2023	mnkd	Effective Income Tax Rate Reconciliation Permanent Items EffectiveIncomeTaxRateReconciliationPermanentItems	-0.028
CY2022	mnkd	Effective Income Tax Rate Reconciliation Permanent Items EffectiveIncomeTaxRateReconciliationPermanentItems	-0.001
CY2021	mnkd	Effective Income Tax Rate Reconciliation Permanent Items EffectiveIncomeTaxRateReconciliationPermanentItems	-0.044
CY2023	mnkd	Effective Income Tax Rate Reconciliation Officers Compensation EffectiveIncomeTaxRateReconciliationOfficersCompensation	-0.353
CY2022	mnkd	Effective Income Tax Rate Reconciliation Officers Compensation EffectiveIncomeTaxRateReconciliationOfficersCompensation	-0.011
CY2021	mnkd	Effective Income Tax Rate Reconciliation Officers Compensation EffectiveIncomeTaxRateReconciliationOfficersCompensation	0
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.056
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.004
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.003
CY2023	mnkd	Effective Income Tax Rate Reconciliation Expirations Of Attribute EffectiveIncomeTaxRateReconciliationExpirationsOfAttribute	0.004
CY2022	mnkd	Effective Income Tax Rate Reconciliation Expirations Of Attribute EffectiveIncomeTaxRateReconciliationExpirationsOfAttribute	-0.132
CY2021	mnkd	Effective Income Tax Rate Reconciliation Expirations Of Attribute EffectiveIncomeTaxRateReconciliationExpirationsOfAttribute	-0.059
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.091
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.072
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	0.112
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.10
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.002
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.002
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.15
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	698200000
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-6800000
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	-9900000
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	2000000000
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	1300000000
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Not Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration	494000000
CY2023	us-gaap	Operating Loss Carryforwards Limitations On Use OperatingLossCarryforwardsLimitationsOnUse	Pursuant to IRC Sections 382 and 383, annual use of the Company’s federal and California net operating loss and research and development credit carryforwards may be limited in the event a cumulative change in ownership of more than 50% occurs within a three-year period.
CY2004Q3	mnkd	Operating Loss Carryforwards Subject To Limitation OperatingLossCarryforwardsSubjectToLimitation	105800000
CY2004Q3	mnkd	Net Operating Loss Carryforward Annual Limitation NetOperatingLossCarryforwardAnnualLimitation	13000000
CY2023Q4	mnkd	Deferred Tax Assets Tax Credit Carryforwards Research Expire DeferredTaxAssetsTaxCreditCarryforwardsResearchExpire	1100000
CY2023	mnkd	Research And Development Credit Expired ResearchAndDevelopmentCreditExpired	2023
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	268902000
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	268902000
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	268902000
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	268902000
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	268902000
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	268902000
CY2021	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0
CY2023	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0
CY2022	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	0

Files In Submission

Name	View Source	Status
FilingSummary.xml	Edgar Link	unprocessable
0000950170-24-021423-index-headers.html	Edgar Link	pending
0000950170-24-021423-index.html	Edgar Link	pending
0000950170-24-021423.txt	Edgar Link	pending
0000950170-24-021423-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
img30090097_0.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mnkd-20231231.htm	Edgar Link	pending
mnkd-20231231.xsd	Edgar Link	pending
mnkd-ex10_29.htm	Edgar Link	pending
mnkd-ex10_4.htm	Edgar Link	pending
mnkd-ex10_6.htm	Edgar Link	pending
mnkd-ex23_1.htm	Edgar Link	pending
mnkd-ex31_1.htm	Edgar Link	pending
mnkd-ex31_2.htm	Edgar Link	pending
mnkd-ex32_1.htm	Edgar Link	pending
mnkd-ex32_2.htm	Edgar Link	pending
mnkd-ex4_3.htm	Edgar Link	pending
mnkd-ex97.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
mnkd-20231231_htm.xml	Edgar Link	completed
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MNKD
MANNKIND CORP Stock $mnkd

2024 Q1 Form 10-K Financial Statement

#000095017024021423 Filed on February 27, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MNKD MANNKIND CORP Stock $mnkd

2024 Q1 Form 10-K Financial Statement

#000095017024021423 Filed on February 27, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MNKD
MANNKIND CORP Stock $mnkd